Bladder cancer: TICE, Connaught BCG yield similar RFS

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
Takeaway
  • No significant difference in recurrence-free survival (RFS) between TICE and Connaught Bacillus Calmette-Guerin (BCG) strains used in combination with interferon in BCG-naïve and BCG-failure patients with nonmuscle-invasive bladder cancer.

Why this matters

  • There has been limited i...